Target intelligence / Profile preview

Iron(III) oxide

Molecular classification
Other
01

Overview

Iron(III) oxide," also known as **ferric oxide** or **Fe₂O₃**, is a common, naturally occurring iron compound found as the mineral hematite[3][9]. It consists of iron in the +3 oxidation state (Fe³⁺) bound to oxygen, forming a reddish-brown solid that is insoluble in water and has the formula Fe₂O₃[3][7][9]. Ferric iron (Fe³⁺) is a chemical state of elemental iron, not a receptor, enzyme, transporter, or specific biological macromolecule. Instead, ferric iron serves as an ionic form of iron present in biological systems—transported in blood mainly by binding to the protein transferrin and stored in ferritin for future physiological use[4][2]. In medicine and physiology, the relevant "targets" for ferric iron are the proteins that bind, transport, or reduce Fe³⁺, such as **transferrin receptors** (e.g., TFR1), **ferritin**, **ferroportin**, and enzymes in iron homeostasis, but "ferric iron" itself is not a molecular therapeutic target[4][2][10]. The entry appears to be a confusion between the iron ion and the relevant protein targets or transporters associated with iron metabolism.

Other names
ferric oxidered iron oxideiron trioxideoxo(oxoferriooxy) ironFe₂O₃
02

Biological functions

Other
03

Disease associations

Other
04

Safety considerations

Iron(III) oxide (ferric iron as Fe³⁺) in bulk chemical form is not itself a therapeutic target and is not pharmacologically targeted; excess or environmental exposure can cause lung irritation if inhaled, but medical safety concerns relate more to iron overload, deficiency, or intoxication from iron salts, not Fe₂O₃ specifically[9].

Beyond the preview

Go deeper on Iron(III) oxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron(III) oxide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call